Abstract:
A method for separating insulin-like growth factor 1 (IGF-1) from mammalian milk of the present invention comprises the steps of: a) separating the mammalian milk into whey and casein; b) recovering fractions containing a large amount of IGF-1; c) separating the fractions containing a large amount of materials corresponding to a molecular weight of the IGF-1 by using ion exchange chromatography; d) separating the fractions containing a large amount of IGF-1 by using gel filtration chromatography; and e) recovering the fractions with 7000-13000 Da or less by passing the fractions containing a large amount of the IGF-1 through a membrane with 7000-13000 Da, and then recovering the IGF-1 by concentrating using a membrane with 700-1300 Da.
Abstract translation:从本发明的哺乳动物乳中分离胰岛素样生长因子1(IGF-1)的方法包括以下步骤:a)将哺乳动物乳分离成乳清和酪蛋白; b)回收含有大量IGF-1的级分; c)使用离子交换色谱法分离含有大量相应于IGF-1分子量的材料; d)使用凝胶过滤层析分离含有大量IGF-1的级分; 和e)通过使含有大量IGF-1的级分通过具有7000-13000Da的膜的7000-13000Da或更低的级分回收级分,然后通过使用具有700-1000Da的膜浓缩来回收IGF-1, 1300 Da
Abstract:
Provided is a composition for preventing or treating menopausal brain disorders which includes Adenophora triphylla var. japonica extract as an active constituent. The composition of the present invention can be usually used as a pharmaceutical composition or a health supplement composition for improving the recognition ability in menopausal women because the composition has recognition ability in menopausal animal models. [Reference numerals] (AA) OVA + Adenophora triphylla var. japonica
Abstract:
PURPOSE: An Oryza Sativa L. extract is provided to suppress the expression of a gene of melanogenesis-related enzyme and to directly suppress melanogenesis, thereby showing superior whitening effects. CONSTITUTION: An ethanol extract of Oryza Sativa L. has whitening effect. Oryza Sativa L. is produced by artificial crossbreeding between Oryza sativa cv. Heugnambyeo and Milyang 153. The ethanol extract is prepared using 75-85 % ethanol. The ethanol extract suppresses melanogenesis and the expression of tyrosinase, TRP-1, and TRP-2 genes.
Abstract:
PURPOSE: A blood glucose reducing agent for menopausal women is provided to enhance an adiponectin concentration in blood and to treat insulin resistance. CONSTITUTION: A blood glucose reducing agent for menopausal women contains an Agrimonia pilosa Ledeb extract. The extract is a water extract of Agrimonia pilosa Ledeb, and enhances an adiponectin concentration in blood. The blood glucose reducing agent is healthy food or a pharmaceutical formulation. [Reference numerals] (AA) Example 1; (BB) Example 2; (CC) Example 3; (DD) Example 4;
Abstract:
PURPOSE: A nanocube liquid crystalline phase composition containing a rubus coreanus extract, and a producing method thereof are provided to improve the bio-membrane permeability of water-soluble and oil-soluble effective components of the rubus coreanus extract inside the body of users. CONSTITUTION: A producing method of a nanocube liquid crystalline phase composition containing a rubus coreanus extract comprises the following steps: dissolving mono-olein in one solvent selected from chloroform, methanol, and ethanol, and mixing an emulsifier to obtain a melt solution; adding water to the rubus coreanus to obtain an aqueous rubus coreanus extract solution; and adding the aqueous rubus coreanus extract solution into the melt solution in a ratio of 1:1-20(v/v), and homogenizing the mixture. The nanocube liquid crystalline phase composition contains 1-50wt% of rubus coreanus extract. The emulsifier is selected from polysorbates, sodium lauryl sulfate, sorbitan fatty acid ester, lecithin, enzymolysis lecithin, glycerin fatty acid ester, saccharose fatty acid ester, propylene glycol fatty acid ester, or polaxamers.
Abstract:
본발명은미백활성이있는신토흑미(Oryza Sativa L.) 에탄올추출물을제공한다. 본발명의신토흑미에탄올추출물은멜라닌합성에관여하는효소의유전자발현을억제하여직접적으로멜라닌합성을저해함으로써확실한미백효과를가져다줄수 있으며, 미백화장품조성물또는건강기능보조식품으로활용이가능하다.